MCID: SBC035
MIFTS: 38

Subacute Cutaneous Lupus Erythematosus malady

Categories: Skin diseases, Rare diseases, Immune diseases

Aliases & Classifications for Subacute Cutaneous Lupus Erythematosus

About this section
Sources:
51Orphanet, 65UMLS, 66UMLS via Orphanet, 28ICD10 via Orphanet, 27ICD10
See all MalaCards sources

Aliases & Descriptions for Subacute Cutaneous Lupus Erythematosus:

Name: Subacute Cutaneous Lupus Erythematosus 51
 
Lupus Erythematosus, Subacute Cutaneous 65

Characteristics:

Orphanet epidemiological data:

51
subacute cutaneous lupus erythematosus:
Prevalence: 1-9/1000000 (United States)

Classifications:

Orphanet: 51 
Rare skin diseases


External Ids:

Orphanet51 163525
UMLS via Orphanet66 C0024140
ICD10 via Orphanet28 L93.1
ICD1027 L93.1
UMLS65 C0024140

Summaries for Subacute Cutaneous Lupus Erythematosus

About this section
Wikipedia:68 Subacute cutaneous lupus erythematosus (SCLE) is a clinically distinct subset of cases of lupus... more...

MalaCards based summary: Subacute Cutaneous Lupus Erythematosus, also known as lupus erythematosus, subacute cutaneous, is related to artery disease and hepatitis. An important gene associated with Subacute Cutaneous Lupus Erythematosus is TRIM21 (Tripartite Motif Containing 21), and among its related pathways are RXR and RAR heterodimerization with other nuclear receptor and Hepatitis C. Affiliated tissues include skin, breast and brain, and related mouse phenotypes are hematopoietic system and immune system.

Related Diseases for Subacute Cutaneous Lupus Erythematosus

About this section

Diseases in the Cutaneous Lupus Erythematosus family:

subacute cutaneous lupus erythematosus

Diseases related to Subacute Cutaneous Lupus Erythematosus via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 237)
idRelated DiseaseScoreTop Affiliating Genes
1artery disease30.1ACE, MBL2, TNF
2hepatitis30.1CTLA4, PRF1, TNF, TYK2
3systemic lupus erythematosus28.4C1QA, CALR, CTLA4, IFNA1, IRF5, MBL2
4cerebritis10.4
5breast cancer10.4
6pyelonephritis10.4
7tuberculosis10.4
8pancreatitis10.4
9glioma10.4
10endotheliitis10.4
11pustulosis of palm and sole10.3ACE, TNF
12schizophrenia10.3
13myocardial infarction10.3
14lung cancer10.3
15hiv-110.3
16asthma10.3
17obesity10.3
18fabry disease10.3
19gastric cancer10.3
20temporal lobe epilepsy10.3
21chronic pyelonephritis10.3
22prostatitis10.3
23olivopontocerebellar atrophy10.3
24cervicitis10.3
25teratoma10.3
26syphilis10.3
27angiokeratoma10.3
28adenoma10.3
29thyroiditis10.3
30lupus erythematosus10.3
31encephalopathy10.3
32cerebral sarcoidosis10.3ACE, TNF
33developmental and speech delay due to sox5 deficiency10.2IRF5, TNF
34autoimmune polyglandular syndrome type 210.2CTLA4, TNF
35t cell immunodeficiency primary10.2PRF1, TNF
36macrophagic myofasciitis10.2IRF5, PRF1, TNF
37androgen insensitivity syndrome, mild10.2CTLA4, TNF
38posterior valve urethra10.2ACE, TNF
39viral meningitis10.2TNF, TRIM21
40hypophosphatasia10.1MBL2, TNF
41rheumatoid arthritis10.1
42colorectal cancer10.1
43prostate cancer10.1
44fibrodysplasia ossificans progressiva10.1
45coronary artery disease10.1
46bacteremia10.1
47west nile virus10.1
48renal cell carcinoma10.1
49h. pylori infection10.1
50sickle cell anemia10.1

Graphical network of the top 20 diseases related to Subacute Cutaneous Lupus Erythematosus:



Diseases related to subacute cutaneous lupus erythematosus

Symptoms for Subacute Cutaneous Lupus Erythematosus

About this section

Drugs & Therapeutics for Subacute Cutaneous Lupus Erythematosus

About this section

Drugs for Subacute Cutaneous Lupus Erythematosus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Alitretinoinapproved, investigationalPhase 2155300-03-8444795
Synonyms:
(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(7e,9Z,11e,13e)-Retinoic acid
(9cis)-retinoic acid
.beta.-Retinoic acid
187175-63-9
1n4h
302-79-4
5300-03-8
56573-65-0
7005-78-9
9 Cis Retinoic Acid
9(Z)-Retinoic acid
9-CIS-RETINOIC ACID
9-CRA
9-cis RA
9-cis Retinoic Acid
9-cis-RA
9-cis-Retinoic acid
9-cis-Tretinoin
9C-RA
9CRA
A-Acido (Argentina)
A-Vitaminsyre
AC-6824
AC1L9GWO
AC1L9MT9
AC1Q1J2J
AGN 100335
AGN 192013
AGN-192013
AKOS000280845
ALRT 1057
ALRT-1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid, Retinoic
Acid, Vitamin A
Acid, trans-Retinoic
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
Alitretinoin (USAN)
Alitretinoin [USAN]
Alitretinoinum
Alitretinoína
Alitrétinoïne
Atra-IV
Atragen
Atralin
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL-4079
BAL4079
BB_NC-1005
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BML2-E06
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001495
BSPBio_001500
Betarretin
C00777
C15493
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEBI:50648
CHEMBL38
CHEMBL705
CID444795
CID449171
CPD000058245
Cordes VAS [Germany]
Cordes vas
D00094
D014212
D02815
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K17
HMS1361K22
HMS1568D16
HMS1791K17
HMS1791K22
HMS1921D14
HMS1989K17
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033965
IDI1_033970
L000833
LG-100057
 
LGD 100057
LGD 1057
LGD-1057
LMPR01090019
LMPR01090022
LS-1154
LS-1328
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
MolPort-002-507-281
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NCGC00161590-01
NCGC00161590-02
NCGC00161590-03
NCGC00161590-04
NCGC00161590-05
NCGC00161590-06
NCGC00161590-07
NSC 122758
NSC 659772
NSC-122758
NSC-659772
NSC122758
NSC659772
Nexret
PDT-002-002
Panretin
Panretin (TN)
Panretin Gel
Panretyn
Panrexin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
R4643_SIGMA
REA
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retinoate
Retinoic acid
Retinova
Retionic acid
Retisol-A
Ro 1-5488
Ro-04-4079
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
SR-05000013784
SR-05000013784-1
ST057075
STK801887
STOCK1N-38565
Salt, Tretinoin Zinc
Solage
Spectrum5_001746
Spectrum5_001933
Spectrum5_001935
Stieva-A
Stieva-a Forte
TRETINON
Toctino
Tretin M
Tretinoin (TN)
Tretinoin Zinc Salt
Tretinoina
Tretinoine
Tretinoino
Tretinoinum
Tri-Luma
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
UPCMLD-DP097:001
UPCMLD-DP097:002
Vesanoid
Vesanoid (TN)
Vesnaroid
Vitamin A acid
Vitinoin
Zinc Salt, Tretinoin
[3H]Retinoic acid
alitretinoina
alitretinoine
alitretinoinum
all-trans-Tretinoin
b-Retinoic acid
beta-Ra
beta-Retinoic acid
bmse000562
nchembio.106-comp3
nchembio.154-comp2
nchembio861-comp8
trans Retinoic Acid
trans-Retinoic acid
tretinoin
tretinoin liposome
2
Tretinoinapproved, investigational, nutraceuticalPhase 2210302-79-45538, 444795
Synonyms:
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
.beta.-Retinoic acid
13497-05-7 (hydrochloride salt)
15-Apo-beta-caroten-15-oic acid
187175-63-9
1n4h
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
302-79-4
5300-03-8
56573-65-0
7005-78-9
9(Z)-Retinoic acid
9-cis-RA
A-Acido (Argentina)
A-Vitaminsyre
A-Vitaminsyre [Denmark]
AC-6824
AC1L9GWO
AC1Q1J2J
AGN 100335
AGN 192013
AKOS000280845
ALRT 1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid A Vit (Belgium, Netherlands)
Acid, Retinoic
Acid, Vitamin A
Acid, all-trans-Retinoic
Acid, beta-all-trans-Retinoic
Acid, trans-Retinoic
Acide retinoique (French)
Acide retinoique (French) (DSL)
Acide retinoique (french) (dsl)
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
All Trans Retinoic Acid
All Trans-Retinoic Acid
All-(E)-Retinoate
All-(E)-Retinoic acid
All-trans Retinoic Acid
All-trans-Retinoate
All-trans-Retinoic acid
All-trans-Tretinoin
All-trans-Vitamin A acid
All-trans-Vitamin A1 acid
Alltrans-retinoic acid
Amnesteem
Atra-IV
Atragen
Atralin
Avita
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL4079
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001500
Betarretin
C00777
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEMBL38
CID444795
CPD000058245
Claravis
Cordes VAS [Germany]
Cordes vas
D00094
D014212
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033970
Isotretinoin Retinoic acid
L000833
LGD 100057
LMPR01090019
LS-1154
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
 
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NSC 122758
NSC-122758
NSC122758
Nexret
Obagi
PDT-002-002
Panretin Gel
Panretyn
Potassium Salt, Tretinoin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
REA
RETINOIC ACID, ALL TRANS
RETINOIC acid
Refissa
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retin-a
Retin-a Micro
Retinoate
Retinoic acid
Retinoic acid, all-trans- (8CI)
Retinova
Retionic Acid
Retionic acid
Retisol-A
Retisol-a
Ro 1-5488
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
ST057075
Salt, Tretinoin Potassium
Salt, Tretinoin Sodium
Salt, Tretinoin Zinc
Sodium Salt, Tretinoin
Solage
Sotret
Spectrum5_001746
Spectrum5_001933
Stieva-A
Stieva-a
Stieva-a Forte
TRETINON
Tretin M
Tretin m
Tretin-x
Tretin.x
Tretinoin
Tretinoin (JAN/USP/INN)
Tretinoin (TN)
Tretinoin 0.1% cream or placebo
Tretinoin Cream
Tretinoin Gel Microsphere
Tretinoin Potassium Salt
Tretinoin Sodium Salt
Tretinoin Zinc Salt
Tretinoin [USAN:INN:BAN]
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Tretinoine (French)
Tretinoine (french) (einecs)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
Tretinx
Tri-Luma
Trétinoïne
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
Vesanoid
Vesanoid (TN)
Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin
Vesnaroid
Vitamin A acid
Vitinoin
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
Zinc Salt, Tretinoin
[3H]Retinoic acid
all trans-Retinoic acid
all-(E)-Retinoic acid
all-(e)-Retinoic acid
all-trans-Retinoic acid
all-trans-Tretinoin
all-trans-Vitamin A acid
all-trans-Vitamin A1 acid
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-b-Retinoic acid
all-trans-beta-Retinoic acid
b-Retinoic acid
beta all trans Retinoic Acid
beta-Ra
beta-Retinoate
beta-Retinoic Acid
beta-Retinoic acid
beta-all-trans-Retinoic acid
bmse000562
nchembio.154-comp2
trans Retinoic Acid
trans-Retinoate
trans-Retinoic acid
tretinoin
tretinoin liposome
tretinoine (French) (EINECS)
3Dermatologic AgentsPhase 24555
4Keratolytic AgentsPhase 2273
5
Pimecrolimusapproved, investigational60137071-32-06447131, 17753757
Synonyms:
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-((E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylvinyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,26,26a-hexadecahydro-5,19-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,17,20,21(4H,23H)-tetrone
137071-32-0
33-Epi-chloro-33-desoxyascomycin
33-epi-Chloro-33-desoxyascomycin
ASM 981
ASM-981
ASM-998
CHEMBL1200686
CID6447131
CID6509979
CID6916008
D05480
DB00337
 
Elidel
Elidel (TN)
I06-1252
LS-181798
MolPort-003-666-749
NCGC00167506-01
Pimecrolimus
Pimecrolimus (JAN/USAN/INN)
Pimecrolimus [USAN:INN:BAN]
Pimecrolimusum
S5004_Selleck
SDZ ASM 981
SDZ-ASM 981
SDZ-ASM-981
UNII-7KYV510875
6Immunologic Factors18483
7Immunosuppressive Agents10422
8Calcineurin Inhibitors1223
9Peripheral Nervous System Agents18510
10Anti-Inflammatory Agents8478
11Analgesics9358
12Analgesics, Non-Narcotic5184
13Anti-Inflammatory Agents, Non-Steroidal3549
14Antirheumatic Agents8496

Interventional clinical trials:

idNameStatusNCT IDPhase
1Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusCompletedNCT01294774Phase 2
2To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCompletedNCT01300208Phase 2
3Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus ErythematosusTerminatedNCT01407679Phase 2
4Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusTerminatedNCT01389895Phase 1
5A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersCompletedNCT02034344Phase 0
6A Non-drug Study Profiling Cutaneous LupusCompletedNCT01923415Phase 0
7Cutaneous Lupus Erythematosus and ElidelRecruitingNCT00222183
8Pilot Tape Harvesting StudyRecruitingNCT02125695
9The Human Microbiome in Immune-Mediated DiseasesRecruitingNCT02394964

Search NIH Clinical Center for Subacute Cutaneous Lupus Erythematosus

Genetic Tests for Subacute Cutaneous Lupus Erythematosus

About this section

Anatomical Context for Subacute Cutaneous Lupus Erythematosus

About this section

MalaCards organs/tissues related to Subacute Cutaneous Lupus Erythematosus:

33
Skin, Breast, Brain, Heart, Lung, Liver, Prostate

Animal Models for Subacute Cutaneous Lupus Erythematosus or affiliated genes

About this section

MGI Mouse Phenotypes related to Subacute Cutaneous Lupus Erythematosus:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.2ACE, CD70, CTLA4, IRF5, MBL2, PRF1
2MP:00053876.3ACE, C1QA, CD70, CTLA4, IRF5, MBD3
3MP:00053766.2ACE, C1QA, CALR, CTLA4, IRF5, MBD3

Publications for Subacute Cutaneous Lupus Erythematosus

About this section

Articles related to Subacute Cutaneous Lupus Erythematosus:

(show top 50)    (show all 288)
idTitleAuthorsYear
1
Development of Structure-Based Vaccines for Ehrlichiosis. (27076151)
2016
2
Diet-induced obesity alters anabolic signalling in mice at the onset of skeletal muscle regeneration. (26052759)
2015
3
IL17 Functions through the Novel REG3I^-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. (26404002)
2015
4
Hydrocephalus in tuberculous meningitis: Incidence, its predictive factors and impact on the prognosis. (23291048)
2013
5
NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis. (24429083)
2013
6
Endocrine autoimmunity in Turner syndrome. (24355069)
2013
7
New and Emerging Risk Factors for Coronary Heart Disease. (23644407)
2013
8
Upregulated expression of ADAM17 is a prognostic marker for patients with gastric cancer. (22668812)
2012
9
Clinical observation of a modified surgical method: posterior vaginal mesh suspension of female rectocele with intractable constipation. (23084670)
2012
10
Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF). (21670263)
2011
11
Inhibition of recombinant L-type voltage-gated calcium channels by positive allosteric modulators of GABAA receptors. (21262851)
2011
12
Involvement of 14-3-3 proteins in the second epidermal growth factor-induced wave of Rac1 activation in the process of cell migration. (21868386)
2011
13
The TGF-I^ co-receptor, CD109, promotes internalization and degradation of TGF-I^ receptors. (21295082)
2011
14
Sirolimus-induced severe hypertriglyceridemia in a lung transplant recipient. (20177353)
2010
15
Inherited thrombophilia as the reason of recurrent miscarriges in the first trimester of pregnancy]. (19886238)
2009
16
Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions. (19058140)
2009
17
Alteration of TLR3 pathways by glucocorticoids may be responsible for immunosusceptibility of human corneal epithelial cells to viral infections. (19452017)
2009
18
Specific effects of escitalopram on neuroendocrine response. (19662384)
2009
19
MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. (19571574)
2009
20
Sclerosing hemangioma with an air halo. (19026830)
2008
21
pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status. (19132993)
2008
22
Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis. (18997868)
2008
23
Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. (17997710)
2008
24
Pseudouveitis--analysis of cases misdiagnosed as posterior uveitis. (16507486)
2006
25
Takayasu's arteritis and ulcerative colitis in a young non-Asian woman: a rare association. (16363285)
2005
26
Leptin responses to short term exercise in college level male rowers. (15618331)
2005
27
p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis. (15832193)
2005
28
Cellular and subcellular localization of the small G protein RhoA in the human and rat embryonic and adult kidney. (12666992)
2003
29
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. (12547726)
2003
30
Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. (11733524)
2002
31
Characterization of adenylyl cyclases in cultured human granulosa cells. (11226046)
2001
32
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. (11203734)
2000
33
A case of noninflammatory corneal edema following anterior-posterior radial keratotomy (Sato's operation) successfully treated by topical corticosteroid. (11033131)
2000
34
Insulin-like growth factor binding protein-3 proteolysis and growth of athyreotic infants in the first weeks of life. (11071083)
2000
35
Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene). (11078452)
2000
36
Conventional molecular diagnosis of steroid 21-hydroxylase deficiency using mismatched primers and polymerase chain reaction. (9378109)
1997
37
Ca2+ effluxes from the sarcoplasmic reticulum vesicles of frog muscle: effects of cyclopiazonic acid and thapsigargin. (8939355)
1996
38
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. (8906022)
1996
39
Effect of sodium chloride supplementation on urinary endothelin-1 excretion in premature infants. (7965436)
1994
40
Lipedema: a clinical entity distinct from lymphedema. (7972431)
1994
41
Biocompatibility study--inflammable cytokine production by the extract from fiber membrane in human peripheral blood]. (7969016)
1994
42
Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology. (7697967)
1994
43
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. (8093742)
1993
44
Hydrophobic coiled-coil domains regulate the subcellular localization of human heat shock factor 2. (8339932)
1993
45
Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. (8307050)
1993
46
Regulation of hepatic transferrin, transferrin receptor and ferritin genes in human siderosis. (1959858)
1991
47
Temperature-dependent tyrosine phosphorylation of microtubule-associated protein kinase in epidermal growth factor-stimulated human fibroblasts. (1663789)
1991
48
Salpingitis isthmica nodosa: radiologic and clinical correlates. (3969459)
1985
49
Choroid plexus papilloma mimicking degenerative brain disease in childhood. (5060466)
1972
50
Effect of pyridoxine deficiency on iron absorption in the rat. (13937825)
1962

Variations for Subacute Cutaneous Lupus Erythematosus

About this section

Expression for genes affiliated with Subacute Cutaneous Lupus Erythematosus

About this section
Search GEO for disease gene expression data for Subacute Cutaneous Lupus Erythematosus.

Pathways for genes affiliated with Subacute Cutaneous Lupus Erythematosus

About this section

GO Terms for genes affiliated with Subacute Cutaneous Lupus Erythematosus

About this section

Biological processes related to Subacute Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1type I interferon signaling pathwayGO:006033710.4IRF5, TYK2
2methylation-dependent chromatin silencingGO:000634610.2MBD1, MBD3
3regulation of type I interferon-mediated signaling pathwayGO:00603389.9IFNA1, TYK2
4negative regulation of growth of symbiont in hostGO:00441309.9MBL2, TNF
5positive regulation of phagocytosisGO:00507669.7CALR, TNF
6complement activation, classical pathwayGO:00069589.3C1QA, MBL2
7defense response to virusGO:00516079.1IFNA1, IRF5, PRF1
8cytokine-mediated signaling pathwayGO:00192219.1IFNA1, IRF5, TRIM21, TYK2

Sources for Subacute Cutaneous Lupus Erythematosus

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet